Literature DB >> 1345151

Hypertension.

B Hoffbrand, M Ross.   

Abstract

1. Accurate measurement of blood pressure using a regularly serviced sphygmomanometer is essential. 2. Severe hypertension requires early treatment. Uncomplicated mild to moderate hypertension requires repeated blood pressure measurements up to three or four months before the diagnosis is confirmed. 3. Personal and family histories, relevant examination and investigations precede treatment. 4. Initial management should aim at reducing weight, improving diet and exercise, and stopping cigarette and excess alcohol consumption. 5. Patients with other risk factors require drug treatment at an earlier stage and at lower blood pressure levels. Essential hypertension is associated with an increased prevalence of risk factors which may need attention. 6. Treatment of asymptomatic hypertension should be considered in patients up to the age of 80. 7. First-line treatment: thiazide diuretics and beta blockers, used in the lowest effective doses, are of proven value and acceptability. The former are by far the cheapest antihypertensive drugs. 8. Second-line treatment: if thiazides and beta blockers are contra-indicated or ineffective, ACE inhibitors, calcium antagonists and alpha blockers should be used. With drugs of these classes the absence of adverse cardiovascular metabolic effects is a theoretical advantage but of uncertain magnitude. 9. Follow-up of patients with borderline levels of raised blood pressure as well as for those on treatment is essential.

Mesh:

Substances:

Year:  1992        PMID: 1345151      PMCID: PMC2560216     

Source DB:  PubMed          Journal:  Occas Pap R Coll Gen Pract        ISSN: 1352-2450


  4 in total

1.  Salt substitutes and potassium intake.

Authors:  J D Swales
Journal:  BMJ       Date:  1991-11-02

Review 2.  Non-pharmacological control of blood pressure.

Authors:  L J Beilin
Journal:  Clin Exp Pharmacol Physiol       Date:  1988-03       Impact factor: 2.557

3.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

Review 4.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.